Rare germline variants in ATM are associated with chronic lymphocytic leukemia.

导出 OA

翻译打印收藏纠错

第一作者： G,Tiao

第一单位： Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.

作者： G,Tiao ^[1] ; M R,Improgo ^[1] ; S,Kasar ^[2] ; W,Poh ^[3] ; A,Kamburov ^[1] ; D-A,Landau ^[2] ; E,Tausch ^[3] ; A,Taylor-Weiner ^[1] ; C,Cibulskis ^[2] ; S,Bahl ^[3] ; S M,Fernandes ^[1] ; K,Hoang ^[1] ; E,Rheinbay ^[2] ; H T,Kim ^[3] ; J,Bahlo ^[4] ; S,Robrecht ^[1] ; K,Fischer ^[1] ; M,Hallek ^[1] ; S,Gabriel ^[2] ; E S,Lander ^[2] ; S,Stilgenbauer ^[1] ; C J,Wu ^[5] ; A,Kiezun ^[6] ; G,Getz ^[6] ; J R,Brown ^[6]

作者单位： Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA. ^[1] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. ^[2] Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. ^[3] Department of Internal Medicine III, Ulm University, Ulm, Germany. ^[4] Department of Computational Biology and Biostatistics, Dana-Farber Cancer Institute, Boston, MA, USA. ^[5] Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University Hospital, Cologne, Germany. ^[6] Department of Pathology, Massachusetts General Hospital, Boston, MA, USA. ^[7] Department of Pathology, Harvard Medical School, Boston, MA, USA. ^[8]